TF and infection: Our TF trigger methodology identified one community (Kakalapere) with a 2015–2016 TF prevalence ≥5%, anti-Pgp3 seroprevalence >15% and detectable ocular Ct infection and a neighbouring village with anti-pgp3 antibodies of >25%.